NK cells are cytotoxic components of innate lymphoid cells (ILC) that provide a first line of
defense against viral infections and contribute to control tumor growth and metastasis. Their …

Natural killer (NK) cell-mediated cancer immunotherapy has grown significantly over the
past two decades. More recently, multi-specific engagers have been developed as cancer …

Human adaptive-like natural killer (NK) cells express low levels of FcεRIγ (FcRγ−/low) and
are reported to accumulate during COVID-19 infection; however, the mechanism underlying …

Natural killer (NK) cells are innate lymphocytes that can kill diseased-or virally-infected cells,
mediate antibody dependent cytotoxicity and produce type I immune-associated cytokines …

Post-COVID syndrome develops in 10–20% of people who have recovered from COVID-19
and it is characterized by impaired function of the nervous, cardiovascular, and immune …

In the setting of viral challenge, natural killer (NK) cells play an important role as an early
immune responder against infection. During this response, significant changes in the NK cell …

Although IL-2 was first recognized as growth factor for T cells, it is now also appreciated to
be a key regulator of T cells through its effects on regulatory T cells (Treg). The IL-2 receptor …

Infections with human cytomegalovirus (HCMV) are often asymptomatic in healthy adults but
can be severe in people with a compromised immune system. While several studies have …

Despite significant progress in recent years, the therapeutic approach of the multiple
different forms of human cancer often remains a challenge. Besides the well-established …

Natural killer (NK) cells hold promise in cancer treatment due to their ability to
spontaneously lyse cancer cells. For clinical use, high quantities of pure, functional NK cells …